The brain contains IGF-1 receptors, and the growth factor plays roles in neural development and maintenance
The best results are often achieved through multiple sessions
Two makers of GLP-1s, Eli Lilly and Novo Nordisk, established direct-to-consumer programs to allow patients to buy the medicines without using insurance at prices as low as $149 for starter doses and between $250 and $375 for monthly maintenance doses
To date, dulaglutide, semaglutide, and tirzepatide have been the three predominant GLP-1 therapeutics employed in the treatment of T2DM, and their applications have been broadened to include weight management
In this respect, OCTN2 targeted nanoparticles have been exploited for improving paclitaxel delivery (Kou et al., 2018)